Mutations in the iron-sulfur cluster ligands of the human ferrochelatase lead to erythropoietic protoporphyria.
暂无分享,去创建一个
S. Friedman | M. Dorsey | X. Schneider-Yin | J. Deybach | L. Gouya | S. Kojima | Yasuhiro Suzuki | K. Shimokado | S. Hayashi | M. Crippa | Jun Shimada | U. B. Rüfenacht | Gloria C. Ferreira
[1] S. Philipsen,et al. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. , 1999, Nucleic acids research.
[2] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[3] S. Friedman,et al. Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. , 1998, The Journal of biological chemistry.
[4] S. Friedman,et al. Molecular regulation of hepatic fibrogenesis. , 1998, Journal of hepatology.
[5] M. Terada,et al. Cloning the cDNA for a New Human Zinc Finger Protein Defines a Group of Closely Related Krüppel-like Transcription Factors* , 1998, The Journal of Biological Chemistry.
[6] R. Urrutia,et al. Molecular Cloning and Characterization of TIEG2Reveals a New Subfamily of Transforming Growth Factor-β-inducible Sp1-like Zinc Finger-encoding Genes Involved in the Regulation of Cell Growth* , 1998, The Journal of Biological Chemistry.
[7] S. Friedman,et al. Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[8] Y. Nagamine,et al. Role of Tissue-Specific Transcription Factor LFB3 in a Cyclic AMP-Responsive Enhancer of the Urokinase-Type Plasminogen Activator Gene in LLC-PK1 Cells , 1998, Molecular and Cellular Biology.
[9] M. Horikoshi,et al. Isolation and initial characterization of GBF, a novel DNA-binding zinc finger protein that binds to the GC-rich binding sites of the HIV-1 promoter. , 1998, Journal of biochemistry.
[10] Y. Nagamine,et al. UV Irradiation Induces the Murine Urokinase-Type Plasminogen Activator Gene via the c-Jun N-Terminal Kinase Signaling Pathway: Requirement of an AP1 Enhancer Element , 1998, Molecular and Cellular Biology.
[11] R. Hynes,et al. Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo , 1998, Cell.
[12] Hong Wang,et al. Human EZF, a Krüppel-like Zinc Finger Protein, Is Expressed in Vascular Endothelial Cells and Contains Transcriptional Activation and Repression Domains* , 1998, The Journal of Biological Chemistry.
[13] P. Carmeliet,et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation , 1997, Nature Genetics.
[14] Z. Werb. ECM and Cell Surface Proteolysis: Regulating Cellular Ecology , 1997, Cell.
[15] P. Carmeliet,et al. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. , 1997, Circulation research.
[16] S. Kojima,et al. Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-beta in liver stellate cells. , 1997, Hepatology.
[17] J. Berthelsen,et al. Characterization of UEF-4, a DNA-binding protein required for transcriptional synergism between two AP-1 sites in the human urokinase enhancer. , 1997, Journal of Biological Chemistry.
[18] P. Carmeliet,et al. Involvement of u‐PA in the anti‐apoptotic activity of TGFβ for vascular smooth muscle cells , 1997, FEBS letters.
[19] S. Friedman,et al. Early genes induced in hepatic stellate cells during wound healing. , 1997, Gene.
[20] G. Gores,et al. Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. , 1997, The Journal of clinical investigation.
[21] L. Zanetta,et al. Control of type IV collagenase activity by components of the urokinase–plasmin system: a regulatory mechanism with cell‐bound reactants , 1997, The EMBO journal.
[22] Paul Martin,et al. Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.
[23] J. Bocco,et al. A Novel Human Zinc Finger Protein That Interacts with the Core Promoter Element of a TATA Box-less Gene* , 1997, The Journal of Biological Chemistry.
[24] D. Rifkin,et al. Latent Transforming Growth Factor-β Binding Protein Domains Involved in Activation and Transglutaminase-dependent Cross-Linking of Latent Transforming Growth Factor-β , 1997, The Journal of cell biology.
[25] R. Masood,et al. Glucocorticoids induce Kaposi's sarcoma cell proliferation through the regulation of transforming growth factor-beta. , 1997, Blood.
[26] J. Iredale,et al. Pathogenesis of liver fibrosis. , 1997, Clinical science.
[27] F. Blasi,et al. Functional characterization of COM, a DNA region required for cooperation between AP-1 sites in urokinase gene transcription. , 1996, Oncogene.
[28] Michael F. Seldin,et al. A Gene for a Novel Zinc-finger Protein Expressed in Differentiated Epithelial Cells and Transiently in Certain Mesenchymal Cells* , 1996, The Journal of Biological Chemistry.
[29] M. Abe,et al. Ets‐1 regulates angiogenesis by inducing the expression of urokinase‐type plasminogen activator and matrix metalloproteinase‐1 and the migration of vascular endothelial cells , 1996, Journal of cellular physiology.
[30] V. Tkachuk,et al. REGULATION AND ROLE OF UROKINASE PLASMINOGEN ACTIVATOR IN VASCULAR REMODELLING , 1996, Clinical and experimental pharmacology & physiology.
[31] J. M. Shields,et al. Identification and Characterization of a Gene Encoding a Gut-enriched Krüppel-like Factor Expressed during Growth Arrest* , 1996, The Journal of Biological Chemistry.
[32] N. Khalil,et al. Plasmin regulates the activation of cell-associated latent TGF-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. , 1996, American journal of respiratory cell and molecular biology.
[33] S. Orkin,et al. Isolation and characterization of the cDNA encoding BKLF/TEF-2, a major CACCC-box-binding protein in erythroid cells and selected other cells , 1996, Molecular and cellular biology.
[34] Amyj . Williams,et al. Egr-1-Induced Endothelial Gene Expression: A Common Theme in Vascular Injury , 1996, Science.
[35] M. Reidy,et al. Migration of arterial wall cells. Expression of plasminogen activators and inhibitors in injured rat arteries. , 1996, Circulation research.
[36] J. Berthelsen,et al. Purification and Characterization of UEF3, A Novel Factor Involved in the Regulation of the Urokinase and Other AP-1 Controlled Promoters (*) , 1996, The Journal of Biological Chemistry.
[37] J. Lingrel,et al. Isolation of a gene encoding a functional zinc finger protein homologous to erythroid Krüppel-like factor: identification of a new multigene family , 1995, Molecular and cellular biology.
[38] M. Schmitt,et al. Inhibition of NF-KB-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAl-1 , 1995 .
[39] D. Rifkin,et al. Characterization of latent TGF-beta activation by murine peritoneal macrophages. , 1995, Journal of immunology.
[40] K. Helin,et al. A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor gene. , 1995, Blood.
[41] S. Kojima,et al. Midkine Enhances Fibrinolytic Activity of Bovine Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.
[42] D. Rifkin,et al. Lipopolysaccharide inhibits activation of latent transforming growth factor‐β in bovine endothelial cells , 1995, Journal of cellular physiology.
[43] W. Border,et al. Transforming Growth Factor β in Tissue Fibrosis , 1994 .
[44] R. Lawn,et al. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice , 1994, Nature.
[45] E. Allan,et al. Plasminogen‐dependent activation of latent transforming growth factor beta (TGFβ) by growing cultures of osteoblast‐like cells , 1993, Journal of cellular physiology.
[46] D. Rifkin,et al. Mechanism of retinoid‐induced activation of latent transforming growth factor‐β in bovine endothelial cells , 1993, Journal of cellular physiology.
[47] J. Bieker,et al. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Krüppel family of nuclear proteins , 1993, Molecular and cellular biology.
[48] Y Fujii-Kuriyama,et al. cDNA cloning and transcriptional properties of a novel GC box-binding protein, BTEB2. , 1993, Nucleic acids research.
[49] D. Rifkin,et al. Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity , 1992, The Journal of cell biology.
[50] T. Gelehrter,et al. Regulatory sequences and protein-binding sites involved in the expression of the rat plasminogen activator inhibitor-1 gene. , 1992, The Journal of biological chemistry.
[51] D. Rifkin,et al. Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self- regulating system , 1990, The Journal of cell biology.
[52] D. Belin,et al. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. , 1990, Circulation research.
[53] R. Tjian,et al. Distinct regions of Sp1 modulate DNA binding and transcriptional activation. , 1988, Science.
[54] R. Tjian,et al. Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif , 1988, Cell.
[55] P. Verde,et al. An upstream enhancer and a negative element in the 5' flanking region of the human urokinase plasminogen activator gene. , 1988, Nucleic acids research.
[56] N. Kaminski,et al. The Integrin avb6 Binds and Activates Latent TGFb1: A Mechanism for Regulating Pulmonary Inflammation and Fibrosis , 1999 .
[57] L. Bonewald,et al. Activation of latent transforming growth factor beta during Chlamydia trachomatis-induced murine pneumonia. , 1996, Research in microbiology.
[58] D. Rifkin,et al. Biology and biochemistry of proteinases in tumor invasion. , 1993, Physiological reviews.
[59] P. Brauer,et al. Cranial neural crest cells synthesize and secrete a latent form of transforming growth factor beta that can be activated by neural crest cell proteolysis. , 1993, Developmental biology.